Physician

Mwafa Turjman, M.D.

According to 2025 Medicare claims, Mwafa Turjman, M.D. (NPI: 1568754661) practices urology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is LIMA MEMORIAL PROFESSIONAL CORPORATION (NPI: 1457474900; TIN: 341935236) and primary practice location at 45804-2800.

Turjman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 383 traditional Medicare patients, billed 944 HCPCS/CPT codes, and received $93,343 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 480 prescription claims across 194 beneficiaries totaling $88,600 in drug costs, led by Orgovyx (Relugolix). 2021 DME data shows 19 claims. Open Payments data shows 22 records totaling $404. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $19,161 and ending at $93,343. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $679 to $88,600. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	79	241	$19,161
2019	222	2,462	$82,373
2020	213	5,873	$84,442
2021	232	4,818	$94,899
2022	292	678	$66,258
2023	270	718	$62,182
2024	383	944	$93,343

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	22	$679
2017	11	30	$728
2018	27	68	$2,479
2019	80	276	$12,473
2020	102	300	$32,724
2021	133	373	$24,789
2022	124	306	$17,089
2023	124	305	$30,647
2024	194	480	$88,600

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	17	$2,293
2021	N/R	19	$5,702
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	59	62	$94
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	89	89	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	150	189	$66
52000	Diagnostic exam of bladder and urethra using an endoscope	85	101	$53
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	67	69	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orgovyx	Relugolix	15	450	$39,681
Myrbetriq	Mirabegron	31	1,650	$24,716
Tamsulosin Hcl	Tamsulosin Hcl	131	8,678	$1,896
Tolterodine Tartrate Er	Tolterodine Tartrate	12	1,080	$1,664
Finasteride	Finasteride	124	7,273	$1,195

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$404	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mwafa Turjman, M.D.?

Tedicare shows public-source Medicare data for Mwafa Turjman, M.D. (NPI 1568754661), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mwafa Turjman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mwafa Turjman, M.D.?

Mwafa Turjman, M.D. is linked to LIMA MEMORIAL PROFESSIONAL CORPORATION (billing NPI 1457474900) in the available physician profile data.

Does Mwafa Turjman, M.D. have Open Payments data?

Mwafa Turjman, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.